A cannabidiol precursor produces anti-convulsant effects in a preliminary study A study shows that the precursor of cannabidiol (CBD) olivetolic acid has had
GW Pharma's Epidiolex approved by the European Medicines Agency The Committee for Medicinal Products for Human Use (CHMP), a body of the European Medicines Agency